Fatal interaction between ritonavir and MDMA

被引：86
作者：
Henry, JA
Hill, IR
机构：
[1] St Marys Hosp, Imperial Coll Sch Med, Acad Dept Accid & Emergency Med, London W2 1NY, England
[2] United Med & Dent Sch Guys & St Thomas Hosp, Dept Forens Med, London SE1 9RT, England
来源：
LANCET | 1998年 / 352卷 / 9142期
关键词：
D O I：
10.1016/S0140-6736(05)79824-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1751 / 1752
页数：2
相关论文
共 5 条
  • [1] Protease inhibitors in patients with HIV disease - Clinically important pharmacokinetic considerations
    Barry, M
    Gibbons, S
    Back, D
    Mulcahy, F
    [J]. CLINICAL PHARMACOKINETICS, 1997, 32 (03) : 194 - 209
  • [2] CLINICAL-SIGNIFICANCE OF THE SPARTEINE-DEBRISOQUINE OXIDATION POLYMORPHISM
    BROSEN, K
    GRAM, LF
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (06) : 537 - 547
  • [3] TOXICITY AND DEATHS FROM 3,4-METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY)
    HENRY, JA
    JEFFREYS, KJ
    DAWLING, S
    [J]. LANCET, 1992, 340 (8816) : 384 - 387
  • [4] ROBERTS L, 1993, J ACCID EMERG MED, V11, P53
  • [5] THE DEMETHYLENATION OF METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY) BY DEBRISOQUINE HYDROXYLASE (CYP2D6)
    TUCKER, GT
    LENNARD, MS
    ELLIS, SW
    WOODS, HF
    CHO, AK
    LIN, LY
    HIRATSUKA, A
    SCHMITZ, DA
    CHU, TYY
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 47 (07) : 1151 - 1156
1